scholarly journals Interrogating Functional Amyloid Formation using Small Molecules

2018 ◽  
Vol 114 (3) ◽  
pp. 227a
Author(s):  
Elizabeth Gichana
2020 ◽  
Vol 11 ◽  
Author(s):  
Anthony Balistreri ◽  
Ethan Kahana ◽  
Soorya Janakiraman ◽  
Matthew R. Chapman

2020 ◽  
Vol 295 (21) ◽  
pp. 7544-7553 ◽  
Author(s):  
Dexter N. Dean ◽  
Jennifer C. Lee

The premelanosomal protein (PMEL17) forms functional amyloid fibrils involved in melanin biosynthesis. Multiple PMEL17 isoforms are produced, two of which arise from excision of a cryptic intron within the amyloid-forming repeat (RPT) domain, leading to long (lRPT) and short (sRPT) isoforms with 10 and 7 imperfect repeats, respectively. Both lRPT and sRPT isoforms undergo similar pH-dependent mechanisms of amyloid formation and fibril dissolution. Here, using human PMEL17, we tested the hypothesis that the minor, but more aggregation-prone, sRPT facilitates amyloid formation of lRPT. We observed that cross-seeding by sRPT fibrils accelerates the rate of lRPT aggregation, resulting in propagation of an sRPT-like twisted fibril morphology, unlike the rodlike structure that lRPT normally adopts. This templating was specific, as the reversed reaction inhibited sRPT fibril formation. Despite displaying ultrastructural differences, self- and cross-seeded lRPT fibrils had a similar β-sheet structured core, revealed by Raman spectroscopy, limited-proteolysis, and fibril disaggregation experiments, suggesting the fibril twist is modulated by N-terminal residues outside the amyloid core. Interestingly, bioinformatics analysis of PMEL17 homologs from other mammals uncovered that long and short RPT isoforms are conserved among members of this phylogenetic group. Collectively, our results indicate that the short isoform of RPT serves as a “nucleator” of PMEL17 functional amyloid formation, mirroring how bacterial functional amyloids assemble during biofilm formation. Whereas bacteria regulate amyloid assembly by using individual genes within the same operon, we propose that the modulation of functional amyloid formation in higher organisms can be accomplished through alternative splicing.


PLoS Biology ◽  
2005 ◽  
Vol 4 (1) ◽  
pp. e6 ◽  
Author(s):  
Douglas M Fowler ◽  
Atanas V Koulov ◽  
Christelle Alory-Jost ◽  
Michael S Marks ◽  
William E Balch ◽  
...  

2018 ◽  
Vol 430 (20) ◽  
pp. 3751-3763 ◽  
Author(s):  
Alissa Bleem ◽  
Gunna Christiansen ◽  
Daniel J. Madsen ◽  
Hans Maric ◽  
Kristian Strømgaard ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (1) ◽  
pp. e0146096 ◽  
Author(s):  
Pengfei Tian ◽  
Kresten Lindorff-Larsen ◽  
Wouter Boomsma ◽  
Mogens Høgh Jensen ◽  
Daniel Erik Otzen

Molecules ◽  
2021 ◽  
Vol 26 (12) ◽  
pp. 3571
Author(s):  
Gareth J. Morgan

Inhibition of amyloid fibril formation could benefit patients with systemic amyloidosis. In this group of diseases, deposition of amyloid fibrils derived from normally soluble proteins leads to progressive tissue damage and organ failure. Amyloid formation is a complex process, where several individual steps could be targeted. Several small molecules have been proposed as inhibitors of amyloid formation. However, the exact mechanism of action for a molecule is often not known, which impedes medicinal chemistry efforts to develop more potent molecules. Furthermore, commonly used assays are prone to artifacts that must be controlled for. Here, potential mechanisms by which small molecules could inhibit aggregation of immunoglobulin light-chain dimers, the precursor proteins for amyloid light-chain (AL) amyloidosis, are studied in assays that recapitulate different aspects of amyloidogenesis in vitro. One molecule reduced unfolding-coupled proteolysis of light chains, but no molecules inhibited aggregation of light chains or disrupted pre-formed amyloid fibrils. This work demonstrates the challenges associated with drug development for amyloidosis, but also highlights the potential to combine therapies that target different aspects of amyloidosis.


2011 ◽  
Vol 286 (18) ◽  
pp. 15955-15963 ◽  
Author(s):  
Vanessa K. Morris ◽  
Qin Ren ◽  
Ingrid Macindoe ◽  
Ann H. Kwan ◽  
Nolene Byrne ◽  
...  

Class I fungal hydrophobins form amphipathic monolayers composed of amyloid rodlets. This is a remarkable case of functional amyloid formation in that a hydrophobic:hydrophilic interface is required to trigger the self-assembly of the proteins. The mechanism of rodlet formation and the role of the interface in this process have not been well understood. Here, we have studied the effect of a range of additives, including ionic liquids, alcohols, and detergents, on rodlet formation by two class I hydrophobins, EAS and DewA. Although the conformation of the hydrophobins in these different solutions is not altered, we observe that the rate of rodlet formation is slowed as the surface tension of the solution is decreased, regardless of the nature of the additive. These results suggest that interface properties are of critical importance for the recruitment, alignment, and structural rearrangement of the amphipathic hydrophobin monomers. This work gives insight into the forces that drive macromolecular assembly of this unique family of proteins and allows us to propose a three-stage model for the interface-driven formation of rodlets.


2013 ◽  
Vol 26 (3) ◽  
pp. 300-315 ◽  
Author(s):  
Brenda Watt ◽  
Guillaume van Niel ◽  
Graça Raposo ◽  
Michael S. Marks

Sign in / Sign up

Export Citation Format

Share Document